文献速递外周血管介入腹部DSA

TIPS术后VIATORR可控扩张支架早期体内扩张的透视定量评估:血流动力学与临床意义

Fluoroscopic quantification of early in vivo expansion of VIATORR controlled expansion stent-grafts after TIPS: hemodynamic and clinical implications.
PubMed 文献 · Abdom Radiol (NY) · 2026-06-30

单中心回顾性队列纳入177例肝硬化TIPS患者(108例传统VTS,69例VCX),透视测量VCX中段直径从植入时8.0mm增至3个月平均8.65mm(P<0.001),PPG从术后即刻7.7mmHg升至3个月11.6mmHg(P<0.001),直径变化与PPG变化无显著相关;PSM后132例分析,VCX组6个月OHE累积发生率数值更高但无统计学差异(HR 11.74,95%CI 0.73-4.16;log-rank P=0.204)。

要点

  • VCX支架可控段在体内并非固定于8mm,3个月平均扩张至8.65mm,随访需关注分流道构型变化。
  • VCX中段直径变化与PPG变化无显著相关,不能仅凭直径推断门脉压力。
  • PSM后VCX与VTS组6个月OHE发生率无统计学差异,但HR置信区间宽,需谨慎解读。
英文原文(摘要)· 点击展开

PURPOSE: The VIATORR Controlled Expansion (VCX) stent-graft was developed to allow more precise control of shunt diameter during transjugular intrahepatic portosystemic shunt (TIPS) creation. However, real-world data on its actual in vivo expansion behavior and short-term clinical implications remain limited. This study aimed to provide fluoroscopic quantitative assessment of early in vivo expansion of VCX stent-grafts and to assess its association with short-term overt hepatic encephalopathy (OHE).

METHODS: This single-center retrospective cohort included consecutive patients with cirrhosis who underwent TIPS using either a legacy 8-mm VIATORR TIPS stent-graft (VTS) or a VCX stent-graft. In the VCX group, stents were initially dilated to 8 mm and further dilated to 10 mm only when post-procedural portal pressure gradient (PPG) remained > 12 mmHg or decreased by < 50% from baseline. Propensity score matching (PSM) was performed to compare short-term clinical outcomes between the VCX and VTS groups. The primary imaging outcome was early in vivo expansion of the VCX controlled mid-segment, assessed by fluoroscopic diameter measurements at implantation and 3-month follow-up. The main clinical safety outcome was new-onset OHE within 6 months after TIPS.

RESULTS: A total of 177 patients were included (108 VTS and 69 VCX). Among VCX patients with paired imaging follow-up, the mid-segment diameter increased from 8.0 mm at implantation to a mean of 8.65 mm at 3 months (range 8.2-9.1 mm; p < 0.001). Mean post-TIPS PPG increased from 7.7 mmHg immediately after TIPS to 11.6 mmHg at 3 months (p < 0.001), with no significant correlation between diameter change and PPG change. After PSM, 132 patients were analyzed. The cumulative 6-month incidence of OHE was numerically higher in the VCX group but did not reach statistical significance compared with VTS (HR 11.74, 95% CI 0.73-4.16; log-rank p = 0.204).

CONCLUSIONS: VCX stent-grafts exhibit measurable early self-expansion after implantation, indicating that the controlled-expansion segment may not remain fixed at the intended 8-mm diameter during early follow-up. While the incidence of OHE did not differ significantly between the VCX group and the VTS group after PSM, the observed expansion underscores the dynamic nature of post-TIPS stent behavior and supports imaging-based follow-up of shunt configuration and hemodynamic status.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Ye Z, Men R, Shen Y, et al. Fluoroscopic quantification of early in vivo expansion of VIATORR controlled expansion stent-grafts after TIPS: hemodynamic and clinical implications. Abdom Radiol (NY). 2026. PMID: 42377541. doi:10.1007/s00261-026-05663-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。